PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#testosterone ×

UPDATED
Regulatorische Updates
25. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Testosterone Enanthate Injectable Products (ANDA083667)
The FDA has discontinued two injectable testosterone enanthate products from Watson Labs, listed under ANDA083667.
UPDATED
Regulatorische Updates
19. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Testosterone Injectable (Product 001) – Submission History
The FDA has marked the testosterone injectable (product 001) as discontinued, with a record of multiple labeling and manufacturing submissions dating back to 1983.